0.00Open0.00Pre Close0 Volume0 Open Interest67.00Strike Price0.00Turnover262.86%IV-20.70%PremiumOct 4, 2024Expiry Date17.49Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9149Delta0.0102Gamma4.66Leverage Ratio-0.5712Theta0.0028Rho4.26Eff Leverage0.0091Vega
Boston Scientific Stock Discussion
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
In 2024, biotech stocks had a slow start, with the S&P Biotechnology Select Industry Index returning just under 4% in the first six months, compared to...
Gapping up
$Enphase Energy (ENPH.US)$ 's stock went up by 2.3% after the company reported a better-than-expected operating profit for the second quarter, buoyed by renewed demand in the U.S. market.
$Texas Instruments (TXN.US)$ stock increased by 1.7% as the semiconductor company reported stronger-than-expected earnings for the second quarter, with adjusted earnings per share that exceeded estimates.
$AT&T (T.US)$ ...
Investors have largely priced in the chances of the Federal Reserve cutting interest rates at its September meeting. Combined with rising confidence in a soft landing, the market has continued its rally, with rate-sensitive sectors such as small caps and industrials rising in recent weeks. $Russell 2000 Index (.RUT.US)$